MAPT and Alzheimer disease: These transgenic mice overexpress the human 4R/2N tau isoform bearing the P301L mutation under the control of the neuron-specific murine Thy1 promoter with an accumulation of hyperphosphorylated tau, which serves as a transgenic model for AD and frontotemporal dementia (FTD).